Drug intelligence / Profile preview

nanosized colloids of human serum albumin

Development stage
Unknown
Lead developer
Sorin
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
Administration
Subcutaneous, Intradermal, Intratumoral, Intravenous, Parenteral
01

Overview

Nanosized colloids of human serum albumin (often referred to as human albumin nanocolloid) is a diagnostic radiopharmaceutical kit used primarily for lymphoscintigraphy, sentinel lymph node detection (particularly in breast cancer, melanoma, and head and neck cancers), and bone marrow scintigraphy. The cold kit consists of colloidal nanoparticles of human serum albumin (HSA) with a particle size typically under 80 nm. Upon reconstitution with sodium pertechnetate (99mTc) solution, it forms technetium Tc 99m albumin colloid. Following local (subcutaneous, intradermal, or peritumoral) injection, the nanocolloidal particles drain through lymphatic vessels and are phagocytosed by macrophages in the sentinel lymph nodes, allowing for precise imaging and intraoperative localization of the nodes using a gamma camera or handheld gamma probe. It was originally developed by Sorin and is marketed under brand names such as Nanocoll (GE Healthcare), Nanotop (Rotop Pharmaka), and Nanoalbumon (Medi-Radiopharma).

Brand names
NanocollNanoalbumonNanotopNanoscanSenti-ScintROTOP-nanoHSA
Other names
human albumin nanocolloidnanocolloidal human serum albumintechnetium Tc 99m albumin colloidtechnetium (99mTc) albumin colloid99mTc-human serum albumin colloid99mTc-nanocolloidal albumin99mTc-albumin colloid99mTc-NC-HSAhuman serum albumin colloid

Beyond the preview

Go deeper on nanosized colloids of human serum albumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nanosized colloids of human serum albumin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call